Related Experiment Video
Updated: Aug 8, 2025

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Advancing workforce diversity by leveraging the Clinical and Translational Science Awards (CTSA) program
Tracie Locklear1, Roslyn Lewis1, Faye Calhoun2
1Biomanufacturing Research Institute and Technology Enterprise, Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, USA.
A new program at North Carolina Central University (NCCU) successfully trained diverse students in clinical research, addressing underrepresentation in clinical trials and promoting health equity. This initiative aims to build a competent and diverse research workforce.
Area of Science:
- Health Equity
- Clinical Research Workforce Development
- Medical Education
Background:
- Clinical trials disproportionately underrepresent people of color, contributing to medical mistrust and health disparities.
- Diverse representation in clinical research personnel is crucial for improving trial inclusivity and medical intervention efficacy.
- Historically Black Colleges and Universities (HBCUs) play a vital role in educating underrepresented minority students.
Purpose of the Study:
- To establish a sustainable framework for training a diverse clinical research workforce.
- To increase the participation of underrepresented groups in clinical research.
- To integrate health equity education into clinical research training.
Main Methods:
- North Carolina Central University (NCCU), an HBCU, established a Clinical Research Sciences Program in 2019.
- The program received support from the Duke University Clinical and Translational Science Awards (CTSA) program.
- A two-semester certificate program focused on clinical research and health equity was implemented.
Main Results:
- The program graduated 11 students in its first year.
- Eight of the 11 graduates secured positions as clinical research professionals.
- The program successfully created a pipeline for diverse talent in clinical research.
Conclusions:
- Leveraging CTSA support enabled NCCU to build a robust framework for clinical research education.
- The program demonstrates a successful model for producing a diverse and highly trained clinical research workforce.
- This initiative addresses the critical need for greater diversity in clinical trial participation and research personnel.
More Related Videos
09:55Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
13:12Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...